Management of Bipolar II Disorder during Pregnancy and the Postpartum Period

Main Article Content

Verinder Sharma

Keywords

Management, Bipolar II Disorder, Pregnancy, Postpartum Period

Abstract

The spectrum of bipolar disorder (BPD) includes BP  I,  BP  II,  and  BP  not  otherwise  specified (NOS).  The latter two conditions  are thought  to have a combined lifetime prevalence of 3.5% compared to a prevalence rate of 1.0% for BP I. Despite  the combined  high  prevalence  of BP II and BP NOS,  surprisingly  little is known  about the course and treatment of these disorders during pregnancy and the postpartum period. Brief  hypomanic   symptoms   occur  in  the early puerperium in as many as 15% of women, and there is preliminary evidence that postpartum depression in some patients may be related to BP II or BP NOS. Yet there is paucity of data on the acute,   and   maintenance    treatment   of   major depressive  episodes  during pregnancy  in women with BP II and BP NOS. And there are no psychopharmacological studies on the acute or maintenance treatment of bipolar postpartum depression   to  guide   clinical   decision   making. Also, there is a lack of screening instruments designed   specifically   for   use   before   or   after delivery  in  women  with  suspected  bipolar disorder. This paper reviews  the current literature on the diagnosis, and treatment of BP II and BP NOS during  pregnancy  and  in  the  postpartum  period and makes recommendations for the detection and treatment of these disorders

Abstract 217 | PDF Downloads 129

References

1. Hirschfeld R, Williams J, Spitzer R, et al. Development and Validation of a Screening Instrument for Bipolar Spectrum Disorder: The Mood Disorders Questionnaire. Am J Psychiatry 2000;157:1873-1875.
2. Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2007;64:543-552.
3. Viguera AC, Cohen LS, Baldessarini RJ, Nonacs R. Managing bipolar disorder during pregnancy: weighing the risks and benefits. Can J Psychiatry 2002;47:426-436.
4. Sharma V, Persad E. Effect of pregnancy on three patients with bipolar disorder. Ann Clin Psychiatry 1995;7:39-42.
5. Grof P, Robbins W, Alda M, et al. Protective effect of pregnancy in women with lithiumpresponsive bipolar disorder. Journal of Affect ive Disorders 2000;61:31-39.
6. Kendell RE, Chalmers JC, Platz C. Epidemiology of puerperal psychoses. Br J Psychiatry 1987;150:662-673.
7. Appleby L. Suicide during pregnancy and in the first postnatal year. BMJ 1991;302:137-140.
8. Marzuk PM, Tardiff K, Leon AC, et al. Lower risk of suicide during pregnancy. Am J Psychiatry 1997;154:122-123.
9. Viguera AC, Whitfield T, Baldessarini RJ, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. American Journal of Psychiatry 2007;164: 1817-1824.
10. Blehar MC, DePaulo JR, Jr, Gershon ES, Reich T, Simpson SG, Nurnberger JI, Jr. Women with bipolar disorder: findings from the NIMH genetics initiative sample. Psychopharmacol Bull 1998;34:239-243.
11. Freeman MP, Smith KW, Freeman SA, McElroy, et al. The impact of reproductive events on the course of bipolar disorder in women. J Clin Psychiatry 2002;63:284-287.
12. Glover V, Liddle P, Taylor A, Adams D, Sandler M. Mild hypomania (the highs) can be a feature of the first postpartum week. Association with later depression. British Journal of Psychiatry 1994;164:517-521.
13. Lane A, Keville R, Morris M, Kinsella A, Turner M, Barry S. Postnatal depression and elation among mothers and their partners: prevalence and predictors. British Journal of Psychiatry 1997;171:550-555. 14. Hasegawa M. Mild hypomania phenomenon in Japanese puerperal women. Nursing and Health Sciences 2000;2:231-235.
15. Webster J, Pritchard MA, Creedy D, East C. A simplified predictive index for the detection of women at risk for postnatal depression. Birth 2003;30:101-108.
16. Farías ME, Wenk E, Cordero M. Adaptación de la Escala Highs para la detección de sintomatología hipomaníaca en el puerperio. Trastor. Ánimo 2007;3:27-36.
17. Heron J, Haque S, Oyebode F, Craddock N, Jones I. Hypomania and depression in pregnancy and the postpartum: Are postpartum onset mood symptoms related to bipolar disorder? Bipolar Disorders (submitted).
18. Sharma V, Khan M, Corpse C, Sharma P. Missed bipolarity and psychiatric comorbidity in women with postpartum depression. Bipolar Disorders (Accepted)
19. Benazzi F. Bipolar II Disorder: “Epidemiology, Diagnosis and Management”. CNS Drugs 2007;21:727-740.
20. Sharma V, Khan M, Smith A. A closer look at treatment resistant depression: is it due to a bipolar diathesis? Journal of Affective Disorders 2005;84:251-257.
21. Sharma V. Loss of response to antidepressants and subsequent refractoriness: diagnostic issues in a retrospective case series. Journal of Affective Disorders 2001;64:99-106.
22. Akiskal HS, Benazzi F, Perugi G, et al. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant -suicide controversy. Journal of Affective Disorders 2005;85:245-258.
23. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression: development of the 10item Edinburgh Postnatal Depression Scale. Br Journal Psychiatry 1987;150:782-786.
24. Beck CT, Gable RK. Postpartum Depression Screening Scale: development and psychometric testing. Nurs Res 2000;49:272-282.
25. Newport DJ, Stowe ZN, Viguera AC, et al. Lamotrigine in bipolar disorder: efficacy during pregnancy. Bipolar Disord 2008;10:432-436.
26. Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, Baldessarini RJ. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000;157:179-184.
27. Wisner KL, Hanusa BH, Peindl KS, Perel JM. Prevention of postpartum episodes in women with bipolar disorder. Biol Psychiatry 2004;56:592-596.
28. Sharma V. A cautionary note on the use of antidepressants in postpartum depression. Bipolar Disorders 2006;8:411-414.
29. Newport DJ, Calamaras MR, DeVane CL, et al. Atypical Antipsychotic Administration During Late Pregnancy: Placental Passage and Obstetrical Outcomes. Am J Psychiatry 2007;164:1214-1220.
30. Gentile S. Clinical utilization of atypical antipsychotics in pregnancy and lactation. Ann Pharmacother 2004;38:1265-1271.
31. Dickson RA, Hogg L. Pregnancy of a patient treated with clozapine. Psychiatr Serv 1998;49:1081-1083.
32. Nguyen HN, Lalonde P. Clozapine and pregnancy. Encephale 2003;29:119-124.
33. Newharn JJ, Thomas SH, MacRitchie K, PR McElhatton, RM McAllister-Williams. Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study. BJP 2008;192:333-337.
34. Sharma V, Smith A, Mazmanian D. Olanzapine in the prevention of postpartum psychosis and mood episodes in bipolar disorder. Bipolar Disord 2006;8:400–404.
35. Yatham LN, Kennedy SH, Schaffer A. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) Collaborative Update of CANMAT Guidelines for the Management of Patients with Bipolar Disorder: Update 2008 (Submitted).
36. Jones I, Craddock N. Bipolar disorder and childbirth: the importance of recognizing risk. British Journal of Psychiatry 2005;186:453-454.
37. Sharma V, Mazmanian D. Sleep loss and postpartum psychosis. Bipolar Disorders 2003;5:98- 105.
38. Sharma V, Smith A, Khan M. The relationship between duration of labour, time of delivery, and puerperal psychosis. Journal of Affective Disorders 2004;83:215-220.